Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level CProspective StudyPubMed
[A new treatment option for complex perianal fistulas in Crohn's disease patients; development of darvadstrocel (allogeneic expanded adipose-derived mesenchymal stem cells) in Japan].
Prospective Study on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Nihon Yakurigaku Zasshi (2024) — summary generated from the PubMed abstract.
- 2024
Nihon Yakurigaku Zasshi - Level CCohort StudyPubMed
Real-life effectiveness of allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulizing refractory Crohn's disease.
Cohort Study with a reported sample of 36 on Scar, Autoimmune Research, published in Clin Res Hepatol Gastroenterol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 36
Clin Res Hepatol Gastroenterol - Level BClinical TrialPubMed
Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
Clinical Trial with a reported sample of 11 on Immune Modulation, Autoimmune Research, published in Colorectal Dis (2021) — summary generated from the PubMed abstract.
- 2021
- n = 11
Colorectal Dis23 citations - Level CCase Report / SeriesPubMed
Allogeneic expanded adipose-derived stem cells in the treatment of rectovaginal fistulas in Crohn's disease.
Case Report / Series on Autoimmune Research, published in Colorectal Dis (2020) — summary generated from the PubMed abstract.
- 2020
Colorectal Dis18 citations - Level ARandomized Controlled TrialPubMed
A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacteria
Randomized Controlled Trial with a reported sample of 180 on Systemic / IV, published in BMC Pulm Med (2020) — summary generated from the PubMed abstract.
- 2020
- n = 180
BMC Pulm Med11 citations - Level BRandomized Controlled TrialPubMed
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled
Randomized Controlled Trial with a reported sample of 6 on Tendon Injury, Autoimmune Research, published in Ann Rheum Dis (2016) — summary generated from the PubMed abstract.
- 2016
- n = 6
Ann Rheum Dis205 citations - Level BClinical TrialPubMed
Treatment of Crohn's-Related Rectovaginal Fistula With Allogeneic Expanded-Adipose Derived Stem Cells: A Phase I-IIa Clinical Trial.
Clinical Trial with a reported sample of 10 on Autoimmune Research, published in Stem Cells Transl Med (2016) — summary generated from the PubMed abstract.
- 2016
- n = 10
Stem Cells Transl Med78 citations - Level ARandomized Controlled TrialPubMed
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
Randomized Controlled Trial with a reported sample of 212 on Autoimmune Research, published in Lancet (2016) — summary generated from the PubMed abstract.
- 2016
- n = 212
Lancet774 citations - Level BClinical TrialPubMed
Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial.
Clinical Trial on Autoimmune Research, published in Int J Colorectal Dis (2012) — summary generated from the PubMed abstract.
- 2012
Int J Colorectal Dis245 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406